Home › Breast Cancer › Texas › Killeen
Breast Cancer clinical trials in Killeen, TX
4 studies for Breast Cancer are looking for participants at sites in and around Killeen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecruitingPhase 3
- Baylor Scott and White Medical Center, Temple · 23 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Texas Oncology Gulf Coast, Woodland · 14 mi away
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Baylor Scott & White Medical Center, Temple · 23 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Temple · 23 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN79 studies
- Los Angeles, CA71 studies
- Edison, NJ69 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX54 studies
Other studies in Killeen
- Post-Traumatic Stress Disorder8 studies
- Heart Failure7 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Bladder Cancer5 studies
- Colon Cancer5 studies
- Metastatic Cancer4 studies
- Type 2 Diabetes4 studies
- Endometrial Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.